107 related articles for article (PubMed ID: 21917385)
1. Clinical potential of phycocyanobilin for induction of T regulatory cells in the management of inflammatory disorders.
McCarty MF
Med Hypotheses; 2011 Dec; 77(6):1031-3. PubMed ID: 21917385
[TBL] [Abstract][Full Text] [Related]
2. Phycocyanin and phycocyanobilin from Spirulina platensis protect against diabetic nephropathy by inhibiting oxidative stress.
Zheng J; Inoguchi T; Sasaki S; Maeda Y; McCarty MF; Fujii M; Ikeda N; Kobayashi K; Sonoda N; Takayanagi R
Am J Physiol Regul Integr Comp Physiol; 2013 Jan; 304(2):R110-20. PubMed ID: 23115122
[TBL] [Abstract][Full Text] [Related]
3. Co-administration of Phycocyanobilin and/or Phase 2-Inducer Nutraceuticals for Prevention of Opiate Tolerance.
McCarty MF; Iloki-Assanga S
Curr Pharm Des; 2018; 24(20):2250-2254. PubMed ID: 30039753
[TBL] [Abstract][Full Text] [Related]
4. C-Phycocyanin-derived Phycocyanobilin as a Potential Nutraceutical Approach for Major Neurodegenerative Disorders and COVID-19- induced Damage to the Nervous System.
Pentón-Rol G; Marín-Prida J; McCarty MF
Curr Neuropharmacol; 2021; 19(12):2250-2275. PubMed ID: 33829974
[TBL] [Abstract][Full Text] [Related]
5. Preclinical Studies Suggest Complex Nutraceutical Strategies May Have Potential for Preventing and Managing Sepsis.
McCarty MF
Altern Ther Health Med; 2015; 21 Suppl 2():56-67. PubMed ID: 26308761
[TBL] [Abstract][Full Text] [Related]
6. Clinical potential of Spirulina as a source of phycocyanobilin.
McCarty MF
J Med Food; 2007 Dec; 10(4):566-70. PubMed ID: 18158824
[TBL] [Abstract][Full Text] [Related]
7. Phycocyanobilin promotes PC12 cell survival and modulates immune and inflammatory genes and oxidative stress markers in acute cerebral hypoperfusion in rats.
Marín-Prida J; Pavón-Fuentes N; Llópiz-Arzuaga A; Fernández-Massó JR; Delgado-Roche L; Mendoza-Marí Y; Santana SP; Cruz-Ramírez A; Valenzuela-Silva C; Nazábal-Gálvez M; Cintado-Benítez A; Pardo-Andreu GL; Polentarutti N; Riva F; Pentón-Arias E; Pentón-Rol G
Toxicol Appl Pharmacol; 2013 Oct; 272(1):49-60. PubMed ID: 23732081
[TBL] [Abstract][Full Text] [Related]
8. Spirulina platensis and phycocyanobilin activate atheroprotective heme oxygenase-1: a possible implication for atherogenesis.
Strasky Z; Zemankova L; Nemeckova I; Rathouska J; Wong RJ; Muchova L; Subhanova I; Vanikova J; Vanova K; Vitek L; Nachtigal P
Food Funct; 2013 Nov; 4(11):1586-94. PubMed ID: 24056745
[TBL] [Abstract][Full Text] [Related]
9. Practical strategies for targeting NF-kappaB and NADPH oxidase may improve survival during lethal influenza epidemics.
McCarty MF; Barroso-Aranda J; Contreras F
Med Hypotheses; 2010 Jan; 74(1):18-20. PubMed ID: 19573997
[TBL] [Abstract][Full Text] [Related]
10. Phycocyanin ameliorates mouse colitis
Guo W; Zeng M; Zhu S; Li S; Qian Y; Wu H
Food Funct; 2022 Mar; 13(6):3294-3307. PubMed ID: 35244658
[TBL] [Abstract][Full Text] [Related]
11. Oral phycocyanobilin may diminish the pathogenicity of activated brain microglia in neurodegenerative disorders.
McCarty MF; Barroso-Aranda J; Contreras F
Med Hypotheses; 2010 Mar; 74(3):601-5. PubMed ID: 19576698
[TBL] [Abstract][Full Text] [Related]
12. Carvedilol and spirulina may provide important health protection to smokers and other nicotine addicts: a call for pertinent research.
McCarty MF; O'Keefe JH; DiNicolantonio JJ
Mo Med; 2015; 112(1):72-5. PubMed ID: 25812281
[TBL] [Abstract][Full Text] [Related]
13. The Bioactivities of Phycocyanobilin from Spirulina.
Li Y
J Immunol Res; 2022; 2022():4008991. PubMed ID: 35726224
[TBL] [Abstract][Full Text] [Related]
14. The Cyanobacterial "Nutraceutical" Phycocyanobilin Inhibits Cysteine Protease Legumain.
Wilkinson IVL; Castro-Falcón G; Roda-Serrat MC; Purdy TN; Straetener J; Brauny MM; Maier L; Brötz-Oesterhelt H; Christensen LP; Sieber SA; Hughes CC
Chembiochem; 2023 Mar; 24(5):e202200455. PubMed ID: 36538283
[TBL] [Abstract][Full Text] [Related]
15. Nutraceutical Features of the Phycobiliprotein C-Phycocyanin: Evidence from
Citi V; Torre S; Flori L; Usai L; Aktay N; Dunford NT; Lutzu GA; Nieri P
Nutrients; 2024 Jun; 16(11):. PubMed ID: 38892686
[No Abstract] [Full Text] [Related]
16. C-Phycocyanin ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells.
Pentón-Rol G; Martínez-Sánchez G; Cervantes-Llanos M; Lagumersindez-Denis N; Acosta-Medina EF; Falcón-Cama V; Alonso-Ramírez R; Valenzuela-Silva C; Rodríguez-Jiménez E; Llópiz-Arzuaga A; Marín-Prida J; López-Saura PA; Guillén-Nieto GE; Pentón-Arias E
Int Immunopharmacol; 2011 Jan; 11(1):29-38. PubMed ID: 20971186
[TBL] [Abstract][Full Text] [Related]
17. Assignment of phycocyanobilin in HMPT using triple resonance experiments.
Röben M; Schmieder P
Magn Reson Chem; 2011 Sep; 49(9):543-8. PubMed ID: 21815209
[TBL] [Abstract][Full Text] [Related]
18. Phycocyanobilin is the molecule responsible for the nephroprotective action of phycocyanin in acute kidney injury caused by mercury.
Garcia-Pliego E; Franco-Colin M; Rojas-Franco P; Blas-Valdivia V; Serrano-Contreras JI; Pentón-Rol G; Cano-Europa E
Food Funct; 2021 Apr; 12(7):2985-2994. PubMed ID: 33704296
[TBL] [Abstract][Full Text] [Related]
19. Time-temperature-resolved functional and structural changes of phycocyanin extracted from Arthrospira platensis/Spirulina.
Böcker L; Hostettler T; Diener M; Eder S; Demuth T; Adamcik J; Reineke K; Leeb E; Nyström L; Mathys A
Food Chem; 2020 Jun; 316():126374. PubMed ID: 32066073
[TBL] [Abstract][Full Text] [Related]
20. Rational Design of Key Enzymes to Efficiently Synthesize Phycocyanobilin in
Wang Z; Zhou J; Li J; Du G; Chen J; Zhao X
Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
